These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 5980438
1. [Anabolic treatment combined with an antimitotic agent in order to prevent leukocyte decrease]. Biedermann C, Obolensky W, Scoglio P, Zürcher WO. Ther Umsch; 1966 Dec; 23(12):509-15. PubMed ID: 5980438 [No Abstract] [Full Text] [Related]
2. The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents. Huys J, Van Vaerenbergh PM. Clin Oncol; 1976 Sep; 2(3):207-14. PubMed ID: 1009703 [No Abstract] [Full Text] [Related]
3. [Key problems of chemotherapy for gynecological malignancies]. Tan XJ, Lang JH. Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):561-3. PubMed ID: 23141172 [No Abstract] [Full Text] [Related]
4. The effect of nandrolone phenylpropionate (Durabolin) on the bone-marrow suppression caused by cyclophosphamide. Cooke WM, Burn JI. Br J Surg; 1971 Apr; 58(4):302-3. PubMed ID: 4929363 [No Abstract] [Full Text] [Related]
5. Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metastatic cancer. Spiers AS, DeVita SF, Allar MJ, Richards S, Sedransk N. J Med; 1981 Apr; 12(6):433-45. PubMed ID: 7033426 [Abstract] [Full Text] [Related]
6. Granulocyte-colony stimulating factors for secondary prevention of leucopenia in patients receiving chemotherapy. Lowathanasirikul J, Manusirivithaya S, Tangjitgamol S, Leelahakorn S. J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S47-53. PubMed ID: 17726809 [Abstract] [Full Text] [Related]
7. [Cyclophosphamide in high dosage forms as gynecologic neoplasm therapy]. Tukiainen P. Duodecim; 1968 Oct; 84(12):763-73. PubMed ID: 5685562 [No Abstract] [Full Text] [Related]
8. THE USE OF TRENIMON AND DECA-DURABOLIN IN RECURRENT GYNAECOLOGICAL CARCINOMA. RAURAMO L, GROENROOS M. Ann Chir Gynaecol Fenn; 1964 Oct; 53():115-9. PubMed ID: 14120480 [No Abstract] [Full Text] [Related]
9. [Antimitotic effect of podophyllin derivatives on genital cancers]. Stamm O. Bull Soc R Belge Gynecol Obstet; 1965 Oct; 35(4):287-90. PubMed ID: 5856818 [No Abstract] [Full Text] [Related]
11. [Chemotherapy of tumors of the female genital tract]. Nieminen U. Duodecim; 1968 Jan; 84(12):754-62. PubMed ID: 5685561 [No Abstract] [Full Text] [Related]
12. [Oral cytology during antiblastic treatment]. Zearo C, Molteni P. Ann Ostet Ginecol Med Perinat; 1969 Jan; 91(1):66-70. PubMed ID: 5408037 [No Abstract] [Full Text] [Related]
13. [Behavior of respiratory function during antineoplastic chemotherapy]. Vignali M, Sergi M, Natale N, Scanni A, Trabattoni A, Luerti M, Tomirotti M, Bosisio E. Minerva Ginecol; 1980 Oct; 32(10):899-903. PubMed ID: 7432700 [No Abstract] [Full Text] [Related]
14. Potential underdosing of carboplatin in gynecological malignancies. de Lemos ML, Hamata L, Conklin J, Swenerton K. Gynecol Oncol; 2006 Sep; 102(3):599. PubMed ID: 16815537 [No Abstract] [Full Text] [Related]
15. The leucocyte nadir, a predictor of chemotherapy efficacy? Kvinnsland S. Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282 [No Abstract] [Full Text] [Related]
16. [Our experience in the treatment of leukopenias secondary to antineoplastic therapy]. Raffaglio E, Tealdi D, Odero A. Biol Lat; 1968 Aug; 21(4):889-92. PubMed ID: 5743674 [No Abstract] [Full Text] [Related]
17. [Oncologic chemotherapy in gynecology. Tolerance and side effects]. Aldariz Arias E, Campuzano Alvarez C, Ces Blanco JA. Rev Enferm; 1987 May; 10(105):34-6. PubMed ID: 3648900 [No Abstract] [Full Text] [Related]
18. [Side effects of FEC100]. Endo A, Watanabe T, Kodama H, Shiga C, Kikuchi S, Yokota T. Gan To Kagaku Ryoho; 2008 Mar; 35(3):467-70. PubMed ID: 18347396 [Abstract] [Full Text] [Related]
19. [Nursing of gynecological patients treated by chemotherapy]. Xian M. Zhonghua Hu Li Za Zhi; 1985 Jun; 20(3):156-8. PubMed ID: 3849358 [No Abstract] [Full Text] [Related]
20. [Incidence of bacterial flora in the vagina and urine in patients with gynecologic neoplasms during short-term administration of cytostatics]. Jandovà A, Novotnà J, Skoda V, Trnka V. Cesk Gynekol; 1973 Jul; 38(6):420-2. PubMed ID: 4731601 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]